| Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial S Ramakrishnan, DV Nicolau, B Langford, M Mahdi, H Jeffers, ... The Lancet Respiratory Medicine 9 (7), 763-772, 2021 | 438 | 2021 |
| Blood eosinophil depletion with mepolizumab, benralizumab, and prednisolone in eosinophilic asthma AM Moran, S Ramakrishnan, CA Borg, CM Connolly, S Couillard, ... American Journal of Respiratory and Critical Care Medicine 202 (9), 1314-1316, 2020 | 45 | 2020 |
| Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir. Med. 21, 2213–2600 S Ramakrishnan, DV Nicolau Jr, B Langford, M Mahdi, H Jeffers, ... View PDF View article View in Scopus, 763-772, 2021 | 5 | 2021 |
| Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021 Apr 9: S2213-2600 (21) 00160-0 S Ramakrishnan, DV Nicolau Jr, B Langford, M Mahdi, H Jeffers, ... | 5 | |
| Renaming COPD exacerbations: the UK respiratory nursing perspective C Mwasuku, J King, REK Russell, M Bafadhel BMC Pulmonary Medicine 21, 1-8, 2021 | 2 | 2021 |
| Rethinking COPD Exacerbations: a global patient perspective C Mwasuku, K Krassowska, C Coleman, P Powell, M Bafadhel European Respiratory Journal 58 (suppl 65), 2021 | 2 | 2021 |
| Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19 SP Cass, DV Nicolau, JR Baker, C Mwasuku, S Ramakrishnan, M Mahdi, ... ERJ Open Research, 2024 | | 2024 |
| Nodal analysis determined nasal mucosal-associated mediators were associated with accelerated clinical recovery from SARS-CoV-2 infection S Cass, J Baker, C Mwasuku, S Ramakrishnan, M Mahdi, P Barnes, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Reply to “Ethnicity-based differences in asthma diagnostic thresholds” J Busby, LG Heaney, PE Pfeffer The Journal of Allergy and Clinical Immunology: In Practice 10 (4), 1124-1125, 2022 | | 2022 |
| Patient perspective of participation in COVID-19 clinical trials K Krassowska, C Mwasuku, S Ramakrishnan, B Langford, H Jeffers, ... European Respiratory Journal 58 (suppl 65), 2021 | | 2021 |
| Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial (preprint) S Ramakrishnan, DV Nicolau Jr, B Langford, M Mahdi, H Jeffers, ... | | 2021 |
| Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β2-Adrenoceptors in Acute Asthma AM Moran, S Ramakrishnan, CA Borg, CM Connolly, S Couillard, ... American Journal of Respiratory and Critical Care Medicine 202 (12), 1743-1744, 2020 | | 2020 |
| Budesonida inhalada en el tratamiento del COVID-19 temprano (STOIC): un ensayo controlado aleatorizado de fase 2, abierto S Ramakrishnan, DV Nicolau Jr, B Langford, M Mahdi, H Jeffers, ... | | |
